Syndax Pharmaceuticals (SNDX) EBT Margin (2015 - 2026)
Syndax Pharmaceuticals' EBT Margin was -49.80% in Q2 2026, up 117.24 percentage points from -167.05% a year earlier but down 2.56 percentage points from the prior quarter.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) EBT Margin (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Syndax Pharmaceuticals' EBT Margin was -70.27% through Jun 30, 2026, up 330.43 percentage points year-over-year; for FY2025, it came in at -145.26%, up 1178.98 percentage points from FY2024.
- EBT Margin shows a five-year change of +4662.85 percentage points (FY2020 to FY2025).
- In earlier years, EBT Margin was -1324.24% in FY2024 and 17.70% in FY2021 (+4825.80 pp).
- Quarterly EBT Margin has moved between -1942.20% (Q2 2024) and 75.72% (Q4 2021) over five years.
- Compared with a year earlier, EBT Margin has increased for five straight quarters, with an average year-over-year change of +772.53 percentage points over the last five quarters.
- Per Business Quant data, SNDX's EBT Margin in the three quarters before Q2 2026 was -47.24% (Q1 2026), -84.71% (Q4 2025) and -113.70% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Syndax Pharmaceuticals | 1.59 Bn | -137.74 Mn | 69.58 Mn | -49.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -49.80% |
| Mar 31, 2026 | -47.24% |
| Dec 31, 2025 | -84.71% |
| Sep 30, 2025 | -113.70% |
| Jun 30, 2025 | -167.05% |
| Mar 31, 2025 | -382.08% |
| Dec 31, 2024 | -1,160.59% |
| Sep 30, 2024 | -673.26% |
| Jun 30, 2024 | -1,942.20% |
| Dec 31, 2021 | 75.72% |
| Sep 30, 2021 | -166.45% |
| Jun 30, 2021 | -6,031.66% |
| Mar 31, 2021 | -7,299.74% |
| Dec 31, 2020 | -5,365.53% |
| Sep 30, 2020 | -5,359.10% |
| Jun 30, 2020 | -4,491.56% |
| Mar 31, 2020 | -4,014.78% |
| Dec 31, 2019 | -3,679.74% |
| Sep 30, 2019 | -3,365.17% |
| Jun 30, 2019 | -3,924.27% |
API Access
Syndax Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=SNDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "SNDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=SNDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();